SEQanswers

SEQanswers (http://seqanswers.com/forums/index.php)
-   Events / Conferences (http://seqanswers.com/forums/forumdisplay.php?f=19)
-   -   LAST CALL: Discovering Cancer-Specific Transcripts (http://seqanswers.com/forums/showthread.php?t=46298)

ecSeq Bioinformatics 09-01-2014 07:49 AM

LAST CALL: Discovering Cancer-Specific Transcripts
 
Discovering standard and non-standard RNA transcripts
How to detect canonical splicing, circular RNAs, trans-splicing, and fusion transcripts

When?
October 23rd - 24th 2014

Where?
Leipzig, Germany


Scope and Topics
The purpose of this workshop is to get a deeper understanding in the usage of split-read mapping in order to find splice junctions, predict new isoforms and uncover non-standard RNA molecules, like circularized RNAs or fusion-transcripts. Advantages and disadvantages of the so-called split-reads and their implications on data analyses will be covered. The participants will be trained to understand the mapping approach, to find potential problems/errors and finally to implement their own pipelines. After this course they will be able to find and analyze (non-)standard exon-exon junctions and create ready-to-use analyses pipelines. In the course we will use a real-life RNA-seq dataset from the current market leader illumina.

By the end of this workshop the participants will:
  • understand the implications of splicing or fusion events and the concept of split-reads
  • understand how to detect splice sites using split-read information
  • know how to predict and quantify different isoforms of genes
  • be able to find circularized RNAs or fusion-stranscripts
  • be able to perform differential splicing analyis
  • automate tasks with shell scripting to create reusable data pipelines
  • plot and visualize results
  • be able to reuse all analyses

Find more information at http://www.ecseq.com/workshops/workshop_2014-04.html


All times are GMT -8. The time now is 05:20 AM.

Powered by vBulletin® Version 3.8.9
Copyright ©2000 - 2020, vBulletin Solutions, Inc.